iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
10.15
0.02 (0.20%)
At close: Aug 28, 2025, 3:59 PM
0.20% (1D)
| Bid | 10.17 |
| Market Cap | 448.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -202.41M |
| EPS (ttm) | -4.73 |
| PE Ratio (ttm) | -2.15 |
| Forward PE | -5.08 |
| Analyst | Hold |
| Ask | 10.22 |
| Volume | 11,006,826 |
| Avg. Volume (20D) | 1,341,915 |
| Open | 10.15 |
| Previous Close | 10.13 |
| Day's Range | 10.15 - 10.15 |
| 52-Week Range | 4.80 - 17.63 |
| Beta | 1.49 |
About ITOS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ITOS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ITOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
iTeos Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+17.94%
ITeos Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+13.44%
ITeos Therapeutics shares are trading higher after the company reported topline interim results from its GALAXIES Lung-201 study of Belrestotug + Dostarlimab.
